Aibotics, Inc. (AIBT) stock
AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (+42.86%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Aibotics cash
Cash and short-term investments held at the end of each period.
Aibotics's cash was $233.43K at Jun 30, 2026. For fiscal 2025 it was $255.94K, up 38.3% from the year before. The highest annual figure on record is $1.27M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $255.94K | +38.3% |
| FY2024 | Dec 31, 2024 | $185.10K | -33.7% |
| FY2023 | Dec 31, 2023 | $279.13K | -27.7% |
| FY2022 | Dec 31, 2022 | $385.90K | -69.6% |
| FY2021 | Dec 31, 2021 | $1.27M | +1044.5% |
| FY2020 | Dec 31, 2020 | $110.75K | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $611.50K | -10.1% |
| FY2017 | Dec 31, 2017 | $680.03K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $233.43K | -3.6% |
| Q1 FY2026 | Mar 31, 2026 | $288.86K | +84.3% |
| Q4 FY2025 | Dec 31, 2025 | $255.94K | +38.3% |
| Q3 FY2025 | Sep 30, 2025 | $230.47K | +13.9% |
| Q2 FY2025 | Jun 30, 2025 | $242.18K | -13.5% |
| Q1 FY2025 | Mar 31, 2025 | $156.74K | -57.7% |
| Q4 FY2024 | Dec 31, 2024 | $185.10K | -33.7% |
| Q3 FY2024 | Sep 30, 2024 | $202.36K | -36.2% |
| Q2 FY2024 | Jun 30, 2024 | $279.91K | -17.4% |
| Q1 FY2024 | Mar 31, 2024 | $370.43K | +3.8% |
| Q4 FY2023 | Dec 31, 2023 | $279.13K | -27.7% |
| Q3 FY2023 | Sep 30, 2023 | $316.99K | -27.7% |
| Q2 FY2023 | Jun 30, 2023 | $338.89K | -56.7% |
| Q1 FY2023 | Mar 31, 2023 | $357.03K | -75.9% |
| Q4 FY2022 | Dec 31, 2022 | $385.90K | -69.6% |
| Q3 FY2022 | Sep 30, 2022 | $438.43K | -53.7% |
| Q2 FY2022 | Jun 30, 2022 | $783.38K | +52.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.48M | +1338.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.27M | +1044.5% |
| Q3 FY2021 | Sep 30, 2021 | $947.40K | +703.3% |
| Q2 FY2021 | Jun 30, 2021 | $513.93K | +314.9% |
| Q1 FY2021 | Mar 31, 2021 | $103.05K | -17.5% |
| Q4 FY2020 | Dec 31, 2020 | $110.75K | – |
| Q3 FY2020 | Sep 30, 2020 | $117.93K | -84.4% |
| Q2 FY2020 | Jun 30, 2020 | $123.86K | -80.6% |
| Q1 FY2020 | Mar 31, 2020 | $124.97K | -79.9% |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q3 FY2019 | Sep 30, 2019 | $754.42K | +3.9% |
| Q2 FY2019 | Jun 30, 2019 | $639.72K | -8.4% |
| Q1 FY2019 | Mar 31, 2019 | $621.93K | -8.5% |
| Q4 FY2018 | Dec 31, 2018 | $611.50K | – |
| Q3 FY2018 | Sep 30, 2018 | $725.90K | – |
| Q2 FY2018 | Jun 30, 2018 | $698.64K | – |
| Q4 FY2017 | Dec 31, 2017 | $680.03K | – |
See a number that looks wrong?